Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

GSK hopes real-world data flu app will go viral

Flumji has been developed by MIT Connection Science

GSK GlaxoSmithKline MIT Connection Science Flumoji mobile Android app 

GlaxoSmithKline is sponsoring a new Android mobile app aims to raise awareness, educate users and collect health outcomes data.

Flumoji was developed by MIT Connection Science, a cross-discipline group from the US Institute, and is being positioned as a 'health wizard'.

“Tell it how you feel and it will magically learn how to help protect you from flu and other ailments,” as MIT's description of the app puts it.

Detailed information on how user data will be collected and put to work is not apparent and this lack of transparency, along with the app's multiple purposes, could hold it back.

Nevertheless, GSK hopes Flumoji will 'go viral', as users share the free app online and watch it spread to friends and friends-of-friends, something they can then keep track of a 'Flumoji Spreaders' leaderboard.

Hopefully the app will prove more shareable than the firm's #Flumoji hashtag, which has been used just six times on Twitter to date, with five tweets from GSK and one from an industry observer.

17th January 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics